US · Healthcare

Global Hemp Group Inc (GBHPF)

Drug Manufacturers - Specialty & Generic

Global Hemp Group Inc (GBHPF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GBHPF

P/E ratio

18.00

Global Hemp Group Inc (GBHPF) — FAQ

What is GBHPF's P/E ratio?

The price-to-earnings (P/E) ratio for Global Hemp Group Inc (GBHPF) is 18.00 (data as of 2026-03-24).

Does Global Hemp Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for Global Hemp Group Inc (GBHPF). Check the MyAverix Finance app for the latest dividend data.

What sector is Global Hemp Group Inc in?

Global Hemp Group Inc (GBHPF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is GBHPF listed on?

GBHPF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)